247 related articles for article (PubMed ID: 7712066)
1. Captopril normalises systolic blood pressure in rats with hypertension induced by fetal exposure to maternal low protein diets.
Langley-Evans SC; Jackson AA
Comp Biochem Physiol A Physiol; 1995 Mar; 110(3):223-8. PubMed ID: 7712066
[TBL] [Abstract][Full Text] [Related]
2. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat.
Sherman RC; Langley-Evans SC
Clin Sci (Lond); 1998 Apr; 94(4):373-81. PubMed ID: 9640343
[TBL] [Abstract][Full Text] [Related]
3. Converting enzyme activity and essential hypertension.
Overlack A; Higuchi M; Kolloch R; Stumpe KO
Klin Wochenschr; 1983 Apr; 61(7):377-8. PubMed ID: 6306333
[TBL] [Abstract][Full Text] [Related]
4. Maternal low-protein diet during mouse pre-implantation development induces vascular dysfunction and altered renin-angiotensin-system homeostasis in the offspring.
Watkins AJ; Lucas ES; Torrens C; Cleal JK; Green L; Osmond C; Eckert JJ; Gray WP; Hanson MA; Fleming TP
Br J Nutr; 2010 Jun; 103(12):1762-70. PubMed ID: 20128937
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
[TBL] [Abstract][Full Text] [Related]
6. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
[TBL] [Abstract][Full Text] [Related]
7. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
[TBL] [Abstract][Full Text] [Related]
8. Kinetic studies of the pharmacologic response to captopril in rats. II. Hypotensive effect and plasma angiotensin converting enzyme activity.
Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
J Pharmacobiodyn; 1989 Jan; 12(1):10-7. PubMed ID: 2542517
[TBL] [Abstract][Full Text] [Related]
9. Blockade of angiotensin-converting enzyme or tumor necrosis factor-α reverses maternal high-fat diet-induced sensitization of angiotensin II hypertension in male rat offspring.
Wang XF; Li JD; Huo YL; Zhang YP; Fang ZQ; Wang HP; Peng W; Johnson AK; Xue B
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R351-R359. PubMed ID: 31746626
[TBL] [Abstract][Full Text] [Related]
10. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats.
Wu J; Ding X
J Agric Food Chem; 2001 Jan; 49(1):501-6. PubMed ID: 11170618
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
12. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats.
Forslund T; Tikkanen I; Grönhagen-Riska C; Fyhrquist F
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):416-21. PubMed ID: 6285670
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of the pharmacologic response to captopril in rats. I. Role of the renin-angiotensin system.
Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
J Pharmacobiodyn; 1989 Jan; 12(1):1-9. PubMed ID: 2542516
[TBL] [Abstract][Full Text] [Related]
16. Dose response in captopril therapy of hypertension.
Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
[TBL] [Abstract][Full Text] [Related]
17. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
Ohmura I; Maki E; Naruse T; Ikeda N; Asami T; Sagawa N
Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
[TBL] [Abstract][Full Text] [Related]
20. Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring.
Li HB; Yang T; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 May; 75(5):1315-1324. PubMed ID: 32200676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
